Umberto Vitolo

Trials

Studies that name Umberto Vitolo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:40 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT04433182 · Copanlisib With Rituximab-Bendamustine in Patients With Relapsed-Refractory Diffuse Large B-cell Lymphoma

  Fondazione Italiana Linfomi - ETS · terminated · Diffuse Large B-cell Lymphoma · principal investigator
• Ph3
  NCT02390869 · Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients

  Fondazione Italiana Linfomi - ETS · active not recruiting · Lymphoma, Follicular · study chair
• Ph3
  NCT01827605 · A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

  Fondazione Italiana Linfomi - ETS · completed · Relapsed Follicular Lymphoma · principal investigator
• Ph2/Ph3
  NCT01805557 · Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP.

  Fondazione Italiana Linfomi - ETS · completed · Diffuse Large B-cell Lymphoma Refractory, Diffuse Large B-cell Lymphoma Recurrent · study director
• Ph2
  NCT01523860 · Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma

  Fondazione Italiana Linfomi - ETS · completed · Follicular Lymphoma · study director
• N/A
  NCT01250223 · Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)

  Associazione Angela Serra per la ricerca sul cancro · completed · Lymphoma, Follicular · study chair
• N/A
  NCT00949741 · Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients

  Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie · completed · Diffuse Large Cell Lymphoma, Lymphoblastic Lymphoma, Burkitt's Lymphoma · principal investigator
• Ph2
  NCT00907348 · Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma

  Fondazione Italiana Linfomi - ETS · unknown · Non Hodgkin Lymphoma, Follicular Lymphoma · study director
• Ph2
  NCT00902525 · Zevalin Twice in Aggressive Non-Hodgkin Lymphoma

  Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie · terminated · Diffuse Large B-Cell Lymphoma · principal investigator
• Ph2
  NCT00556127 · Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma

  Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie · completed · Diffuse Large B-Cell Lymphoma, POOR PROGNOSIS · principal investigator
• Ph2
  NCT00509379 · Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma

  Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie · completed · Lymphoma, Non-Hodgkin Lymphoma · principal investigator
• Ph3
  NCT00499018 · Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma

  Fondazione Italiana Linfomi - ETS · unknown · Diffuse Large B-Cell Lymphoma, IPI≥2 · principal investigator
• Ph2
  NCT00210379 · Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma

  International Extranodal Lymphoma Study Group (IELSG) · completed · Lymphoma, B Cell · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.